Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar
Pritchard E. et al, (2024), American Journal of Epidemiology, 193, 1848 - 1860
Predicting future hospital antimicrobial resistance prevalence using machine learning
Vihta K-D. et al, (2024), Communications Medicine, 4
Improving the representativeness of UK’s national COVID-19 Infection Survey through spatio-temporal regression and post-stratification
Pouwels KB. et al, (2024), Nature Communications, 15
Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population
Wei J. et al, (2024), Nature Communications, 15
E. coliphylogeny drives co-amoxiclav resistance through variable expression ofblaTEM-1
Matlock W. et al, (2024)
Predicting future hospital antimicrobial resistance prevalence using machine learning
Vihta K-D. et al, (2023)
COVID-19 vaccination, risk-compensatory behaviours, and contacts in the UK
Buckell J. et al, (2023), Scientific Reports, 13
Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK
Wei J. et al, (2023), Nature Communications, 14
Symptoms and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Positivity in the General Population in the United Kingdom
Vihta KD. et al, (2022), Clinical Infectious Diseases, 75, e329 - e337
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom
Vihta1 KD. et al, (2022), Clinical Infectious Diseases
SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection
Wei J. et al, (2022), Nature Communications, 13
Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines
Wei J. et al, (2022), Nature Medicine, 28, 1072 - 1082
Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance
Pritchard E. et al, (2022), The Lancet Regional Health - Europe, 13, 100282 - 100282
Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom
Walker AS. et al, (2021), New England Journal of Medicine, 385, 2582 - 2585
Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Pouwels KB. et al, (2021), Nature Medicine, 27, 2127 - 2135
Anti-spike antibody response to natural SARS-CoV-2 infection in the general population
Wei J. et al, (2021), Nature Communications, 12